SCHEMBL3453089

SCHEMBL3453089

ClCc1ccc2c(c1)-c1ccccc1C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 2/20 0.47
ATM Q13315 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP17A1 P05093 1/20 0.44
SRD5A2 P31213 1/20 0.43
MAOA P21397 2/20 0.42
CYP1A2 P05177 6/20 0.41
CYP3A4 P08684 4/20 0.41
GPR84 Q9NQS5 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5515193 0.92 ALDH1A1 (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7182969 0.84 NPC1 (0.52) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7190397 0.84 GPR84 (0.52) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL27399387 0.81 TSHR (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL3453563 0.81 NPC1 (0.48) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL5536062 0.81 RAB9A (0.48) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL20491470 0.81 NPC1 (0.52) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL3982676 0.79 ALDH1A1 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL30912172 0.79 SMN1; SMN2 (0.64) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL5016641 0.79 SMN1; SMN2 (0.64) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858824-B2 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them SANOFI-AVENTIS (FR) 2010-12-28 US disclosed
US-20080097117-A1 Aralkyltetrahydropyridines, Their Preparation and Pharmaceutical Compositions Containing Them SANOFI-AVENTIS (FR) 2008-04-24 US disclosed
US-7326723-B2 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same SANOFI-AVENTIS (FR) 2008-02-05 US disclosed
CN-101096337-A Aralkyl carboxylic acid, preparation method and application thereof SANOFI SYNTHELABO (FR) 2008-01-02 CN disclosed
CN-100335464-C Aralkyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them SANOFI SYNTHELABO (FR) 2007-09-05 CN disclosed
EP-1438291-B1 ARALKYL-TETRAHYDRO-PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI AVENTIS (FR) 2005-09-07 EP disclosed
CN-1571770-A Aralkyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them SANOFI SYNTHELABO (FR) 2005-01-26 CN disclosed
US-20050014795-A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same SANOFI-SYNTHELABO (FR) 2005-01-20 US disclosed
EP-1438291-A1 ARALKYL-TETRAHYDRO-PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Sanofi-Aventis (FR) 2004-07-21 EP disclosed
WO-2003033466-A1 ARALKYL-TETRAHYDRO-PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI-SYNTHELABO (FR) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014795-A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same CYCS, NADK, CYP2F1 ALDH1A1 2370/4885NPC1 2301/4885RAB9A 1202/4885
US-20080097117-A1 Aralkyltetrahydropyridines, Their Preparation and Pharmaceutical Compositions Containing Them CYP3A43, CYCS, CCNY ALDH1A1 2661/4885NPC1 2082/4885RAB9A 1673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.